Evidence map›Paper›PMID 39165417›Full record

ArticleGastro hep advances2024

Development and External Validation of a Prediction Model for Colorectal Cancer Among Patients Awaiting Surveillance Colonoscopy Following Polypectomy.

Theodore R Levin, Christopher D Jensen, Amy R Marks, David Schlessinger, Vincent Liu, Natalia Udaltsova, Jessica Badalov, Evan Layefsky, Douglas A Corley, Joshua R Nugent and 1 more

Abstract read
In one paragraph

Article in Gastro hep advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Theodore R LevinDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Christopher D JensenDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Amy R MarksDivision of Research, Kaiser Permanente Northern California, Oakland, California.
David SchlessingerDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Vincent LiuDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Natalia UdaltsovaDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Jessica BadalovDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Evan LayefskyDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Douglas A CorleyDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Joshua R NugentDivision of Research, Kaiser Permanente Northern California, Oakland, California.
Jeffrey K LeeDivision of Research, Kaiser Permanente Northern California, Oakland, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Demand for surveillance colonoscopy can sometimes exceed capacity, such as during and following the coronavirus disease 2019 pandemic, yet no tools exist to prioritize the patients most likely to be diagnosed with colorectal cancer (CRC) among those awaiting surveillance colonoscopy. We developed a multivariable prediction model for CRC at surveillance comparing performance to a model that assigned patients as low or high risk based solely on polyp characteristics (guideline-based model). Methods: Logistic regression was used for model development among patients receiving surveillance colonoscopy in 2014-2019. Candidate predictors included index colonoscopy indication, findings, and endoscopist adenoma detection rate, and patient and clinical characteristics at surveillance. Patients were randomly divided into model development (n = 36,994) and internal validation cohorts (n = 15,854). External validation was performed on 30,015 patients receiving surveillance colonoscopy in 2020-2022, and the multivariable model was then updated and retested. Results: One hundred fourteen, 43, and 71 CRCs were detected at surveillance in the 3 cohorts, respectively. Polyp size ≥10 mm, adenoma detection rate <32.5% or missing, patient age, and ever smoked tobacco were significant CRC predictors; this multivariable model outperformed the guideline-based model (internal validation cohort area under the receiver-operating characteristic curve: 0.73, 95% confidence interval (CI): 0.66-0.81 vs 0.52, 95% CI: 0.45-0.60). Performance declined at external validation but recovered with model updating (operating characteristic curve: 0.72 95% CI: 0.66-0.77). Conclusion: When surveillance colonoscopy demand exceeds capacity, a prediction model featuring common clinical predictors may help prioritize patients at highest risk for CRC among those awaiting surveillance. Also, regular model updates can address model performance drift.

Indexed as

Colonoscopy SurveillanceColorectal CancerPost PolypectomyPrediction ModelRisk Stratification

Identifiers

PMID39165417
PMCPMC11330934

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.